Company intelligence / Profile preview

Calbee

Chiyoda-ku, Marunouchi, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Calbee is a major Japanese snack food manufacturer with a growing focus on functional foods and personalized nutrition. It launched the "Body Granola" service in 2023, leveraging microbiome testing to provide personalized dietary recommendations aimed at improving gut health and sleep quality. This service has enrolled over 30,000 users as of June 2025[5][7]. Calbee’s health business is rapidly expanding, underpinned by scientific collaborations and a medium- to long-term strategy emphasizing food and health[5].

Therapeutic areas: GastroenterologyNeurology
Modalities: Functional foodFood ingredientsDietary supplement
Industry: Food & Nutrition

Partnerships

Metagen (microbiome analysis and personalized healthcare)Cykinso (gut microbiota testing)PepsiCo (business/equity alliance)

Beyond the preview

Go deeper on Calbee.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calbee.

Explore the full profile